Company Analysis

Anika Therapeutics Inc. (ANIK)

Nasdaq: ANIK · Surgical & Medical Instruments & Apparatus · Bedford, MA · filing with the SEC since 1996
Grade5.5
◀ Past 5.7● Present 5.4▶ Future 5.6

Who runs Anika Therapeutics Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Griffin Stephen D.
President and CEO. First filing Jun 2024, latest Jun 5, 2026, 1 filing in all.
Officers reporting now
4
of 9 people with a filing in the last fifteen months
Directors reporting now
5
27 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Griffin Stephen D.President and CEOJun 2024Jun 5, 2026none
Mcleod IanSVP, CAO & TreasurerApr 2025Mar 23, 2026none
Blanchard Cheryl RPresident, CEO, DirectorAug 2018Mar 17, 2026none
Colleran DavidEVP, General Counsel, Corp SecMar 2020Mar 17, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Fischetti Gary PdirectorApr 2023Aug 5, 2026none
Capper Joseph HdirectorJun 2024Jun 23, 2026none
Conley Sheryl LdirectorOct 2021Jun 23, 2026none
Henneman John B IIIdirectorSep 2020Jun 23, 2026none
Richard StephendirectorSep 2020Jun 23, 2026none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ANIK · research, not advice